saquayamycin: isolated from Streptomyces nodosus MH190-16F3; structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
| ID Source | ID |
|---|---|
| PubMed CID | 127271 |
| MeSH ID | M0135648 |
| Synonym |
|---|
| saquayamycin |
| benz(a)anthracene-1,7,12(2h)-trione, 9-(2,6-dideoxy-4-o-((2r-trans)-5,6-dihydro-6-methyl-5-oxo-2h-pyran-2-yl)-beta-d-arabino-hexopyranosyl)-3-((5-((5,6-dihydro-6-methyl-5-oxo-2h-pyran-2-yl)oxy)tetrahydro-6-methyl-2h-pyran-2-yl)oxy)-3,4,4a,12b-tetrahydro-4 |
| 99260-65-8 |
| 4a,8,12b-trihydroxy-9-[4-hydroxy-6-methyl-5-[(6-methyl-5-oxo-2h-pyran-2-yl)oxy]oxan-2-yl]-3-methyl-3-[6-methyl-5-[(6-methyl-5-oxo-2h-pyran-2-yl)oxy]oxan-2-yl]oxy-2,4-dihydrobenzo[a]anthracene-1,7,12-trione |
| DTXSID40912810 |
| 1,5-anhydro-2,6-dideoxy-4-o-(6-methyl-5-oxo-5,6-dihydro-2h-pyran-2-yl)-1-[4a,8,12b-trihydroxy-3-methyl-3-({6-methyl-5-[(6-methyl-5-oxo-5,6-dihydro-2h-pyran-2-yl)oxy]oxan-2-yl}oxy)-1,7,12-trioxo-1,2,3,4,4a,7,12,12b-octahydrotetraphen-9-yl]hexitol |
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 1 (14.29) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 3 (42.86) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 7 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||